Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained IOP Elevation or Ocular Hypotensive Treatment

IMPORTANCE: For the management of retinal disease, use of intravitreous injections of anti-vascular endothelial growth factor has increased. Recent reports have suggested that this therapy may cause persistent intraocular pressure (IOP) elevation and potentially increase the risk of glaucoma in pati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Ophthalmol
Glavni autori: Bressler, Susan B., Almukhtar, Talat, Bhorade, Anjali, Bressler, Neil M., Glassman, Adam R., Huang, Suber S., Jampol, Lee M., Kim, Judy E., Melia, Michele
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496789/
https://ncbi.nlm.nih.gov/pubmed/25719991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.186
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items